dactinomycin and Coronary Restenosis

dactinomycin has been researched along with Coronary Restenosis in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Büllesfeld, L; Gerckens, U; Grube, E; Müller, R	1
Kipshidze, N; Leon, MB; Moses, JW	1
Bett, JH; Buszman, P; Coleman, L; de Feyter, P; den Heijer, P; Glogar, HD; Grube, E; Johnson, R; Marco, J; Miquel, K; Ormiston, JA; Pitney, M; Polonski, L; Schömig, A; Serruys, PW; Sianos, G; Sousa, JE; Suttorp, MJ; Thuesen, L; Veldhof, S; Virmani, R; Whitbourn, R; Wilkins, GT; Zeiher, AM	1
Fox, R	1
Regar, E; Serruys, PW; Sianos, G	1
Carter, AJ; Hiatt, BL; Ikeno, F; Yeung, AC	1

Reviews

2 review(s) available for dactinomycin and Coronary Restenosis

Article	Year
Perspectives of drug-eluting stents: the next revolution. American journal of cardiovascular drugs : drugs, devices, and other interventions, 2002, Volume: 2, Issue:3 Topics: Angioplasty, Balloon, Coronary; Animals; Antineoplastic Agents; Coronary Restenosis; Dactinomycin; Humans; Paclitaxel; Randomized Controlled Trials as Topic; Sirolimus; Stents	2002
Stent development and local drug delivery. British medical bulletin, 2001, Volume: 59 Topics: Angioplasty, Balloon, Coronary; Anti-Bacterial Agents; Antineoplastic Agents; Biodegradation, Environmental; Coronary Restenosis; Dactinomycin; Drug Delivery Systems; Equipment Design; Humans; Myocardial Ischemia; Paclitaxel; Protein Synthesis Inhibitors; Sirolimus; Stents	2001

Trials

1 trial(s) available for dactinomycin and Coronary Restenosis

Article	Year
Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial. Journal of the American College of Cardiology, 2004, Oct-06, Volume: 44, Issue:7 Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Dactinomycin; Death, Sudden, Cardiac; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prospective Studies; Selection Bias; Single-Blind Method; Stents; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional	2004

Article

Year

Actinomycin-eluting stent for coronary revascularization: a randomized feasibility and safety study: the ACTION trial.

Journal of the American College of Cardiology, 2004, Oct-06, Volume: 44, Issue:7

Topics: Aged; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Dactinomycin; Death, Sudden, Cardiac; Drug Administration Schedule; Feasibility Studies; Female; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prospective Studies; Selection Bias; Single-Blind Method; Stents; Time Factors; Treatment Outcome; Tunica Intima; Ultrasonography, Interventional

2004

Other Studies

3 other study(ies) available for dactinomycin and Coronary Restenosis

Article	Year
Drug eluting stents: initial experiences. Zeitschrift fur Kardiologie, 2002, Volume: 91 Suppl 3 Topics: Angiogenesis Inhibitors; Angioplasty, Balloon, Coronary; Animals; Coated Materials, Biocompatible; Coronary Restenosis; Dactinomycin; Drug Delivery Systems; Follow-Up Studies; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Paclitaxel; Pilot Projects; Protein Synthesis Inhibitors; Randomized Controlled Trials as Topic; Safety; Sirolimus; Stents; Swine; Tacrolimus; Time Factors	2002
American Heart Association 2001 scientific sessions: late-breaking science-drug-eluting stents. Circulation, 2001, Nov-20, Volume: 104, Issue:21 Topics: Clinical Trials as Topic; Coronary Restenosis; Dactinomycin; Humans; Paclitaxel; Sirolimus; Stents	2001
Drug-eluting stents for the prevention of restenosis: in quest for the Holy Grail. Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2002, Volume: 55, Issue:3 Topics: Animals; Cell Division; Clinical Trials as Topic; Coated Materials, Biocompatible; Coronary Restenosis; Dactinomycin; Depression, Chemical; Humans; Infusion Pumps, Implantable; Muscle, Smooth, Vascular; Paclitaxel; Sirolimus; Stents	2002